RNS Number : 5247A
  Northwest Biotherapeutics Inc
  04 August 2008
   

 For Immediate Release  August, 4 2008



    Northwest Biotherapeutics
    ("NWBT" or the "Company")

    Director/PDMR Shareholding



    Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US), announced that, on July 16, 2008, Toucan Partners LLC advised the
Company that, on July 15, 2008, it had distributed 2,572,710 shares of Northwest's common stock to Linda F. Powers, Chairperson of
Northwest's Board of Directors.  Ms. Powers is a managing member and fifty percent owner of Toucan Partners, LLC.

    As a result of this transfer, Ms. Powers now directly owns 2,572,710 shares representing 6.05%, and as managing member of Toucan
Partners LLC and Toucan Capital Fund II, LP has an additional indirect interest in 45.42% of, Northwest's issued and outstanding stock.

    After this transfer Toucan Partners, LLC owns no shares of NWBT but has a continuing interest in warrants to purchase 8,832,541 shares
of the Company's common stock.


    For further information, please contact:

 Northwest Biotherapeutics
 Anthony P. Deasey, Chief Financial Officer                    +1 240-497-9024




 Buchanan Communications
 Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane         +44 (0)20 7466 5000
 Johnson / Catherine Breen 

 Collins Stewart
 Adam Cowen/Tim Mickley                                    +44 (0)20 7523 8230



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
MSCPJMRTMMIMBJP

Northw.Bio Regs (LSE:NWBS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Northw.Bio Regs 차트를 더 보려면 여기를 클릭.
Northw.Bio Regs (LSE:NWBS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Northw.Bio Regs 차트를 더 보려면 여기를 클릭.